Bayer

Evotec reaches pre-clinical milestone in Bayer alliance

Evotec and Bayer formed a strategic alliance in October 2012. (Image: iStock/AlexeyVS)

Evotec AG has received a payment of approximately ‎€5m ($5.62m) as part of its strategic alliance with Bayer – which the company says is “well on track and very successful.”

Image: iStock/ArielMieli

CRO Evotec sees spin-out firm as strategic opportunity

PCT Europe took place in Hamburg, Germany

Patient-centric trials to give CROs competitive edge, say sponsors

German CRO joins tenants on Bayer campus

German CRO joins tenants on Bayer campus

Brian Cass, Huntingdon CEO

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

The CoLaborator project is based in San Francisco, California. (Image: Evonne)

Bayer manufactures for biologics start-up in CoLaborator project

PPD's X-Chem is signing a number of deals with Big Pharma

PPD’s X-Chem signs multi-target collaboration with Janssen

Evotec has had a breakthrough year in 2014

European CRO Evotec cashes in on strategic partnerships

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

Covance calls investor suit seeking to derail acquisition meritless

Covance says investor lawsuit seeking to derail LabCorp acquisition ‘without merit’

More Bayer